Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 11, 2024 |
| PDB ID | UniProt ID | Title ▼ | Descriptor |
|---|---|---|---|
| 7KZ1 | O95243 | Human MBD4 glycosylase domain bound to DNA containing an abasic site | |
| 3SRD | P14618 | Human M2 pyruvate kinase in complex with fructose 1-6 bisphosphate and Oxalate. | |
| 1XOI | P06737 | Human Liver Glycogen Phosphorylase A complexed with Chloroindoloyl glycine amide | |
| 7B00 | Q9UHI5 | Human LAT2-4F2hc complex in the apo-state | |
| 7B00 | P08195 | Human LAT2-4F2hc complex in the apo-state | |
| 8E5A | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5A | P54284 | Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5A | P54289 | Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution | |
| 7UHF | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of cinnarizine at 3.1 Angstrom resolution | |
| 7UHF | P54284 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of cinnarizine at 3.1 Angstrom resolution | |
| 7UHF | P54289 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of cinnarizine at 3.1 Angstrom resolution | |
| 8E59 | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution | |
| 8E59 | P54284 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution | |
| 8E59 | P54289 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution | |
| 8E5B | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone and Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5B | P54284 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone and Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5B | P54289 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone and Sofosbuvir at 3.3 Angstrom resolution | |
| 7UHG | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 at 3.0 Angstrom resolution | |
| 7UHG | P54284 | Human L-type voltage-gated calcium channel Cav1.3 at 3.0 Angstrom resolution | |
| 7UHG | P54289 | Human L-type voltage-gated calcium channel Cav1.3 at 3.0 Angstrom resolution | |
| 8WE8 | Q13936 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine, amlodipine and pinaverium at 2.9 Angstrom resolution | |
| 8WE8 | P22947 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine, amlodipine and pinaverium at 2.9 Angstrom resolution | |
| 8WE8 | P54284 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine, amlodipine and pinaverium at 2.9 Angstrom resolution | |
| 8WE8 | P54289 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine, amlodipine and pinaverium at 2.9 Angstrom resolution | |
| 8WE7 | Q13936 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution | |
| 8WE7 | P22947 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution | |
| 8WE7 | P54284 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution | |
| 8WE7 | P54289 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution | |
| 8FHS | Q13936 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of amiodarone and sofosbuvir at 3.3 Angstrom resolution | |
| 8FHS | P54284 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of amiodarone and sofosbuvir at 3.3 Angstrom resolution | |
| 8FHS | P54289 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of amiodarone and sofosbuvir at 3.3 Angstrom resolution | |
| 8WE6 | Q13936 | Human L-type voltage-gated calcium channel Cav1.2 at 2.9 Angstrom resolution | |
| 8WE6 | P54284 | Human L-type voltage-gated calcium channel Cav1.2 at 2.9 Angstrom resolution | |
| 8WE6 | P54289 | Human L-type voltage-gated calcium channel Cav1.2 at 2.9 Angstrom resolution | |
| 8WEA | Q13936 | Human L-type voltage-gated calcium channel Cav1.2 (Class II) in the presence of pinaverium at 3.2 Angstrom resolution | |
| 8WEA | P54289 | Human L-type voltage-gated calcium channel Cav1.2 (Class II) in the presence of pinaverium at 3.2 Angstrom resolution | |
| 8WE9 | Q13936 | Human L-type voltage-gated calcium channel Cav1.2 (Class I) in the presence of pinaverium at 3.0 Angstrom resolution | |
| 8WE9 | P54284 | Human L-type voltage-gated calcium channel Cav1.2 (Class I) in the presence of pinaverium at 3.0 Angstrom resolution | |
| 8WE9 | P54289 | Human L-type voltage-gated calcium channel Cav1.2 (Class I) in the presence of pinaverium at 3.0 Angstrom resolution | |
| 7Y1R | P01137 | Human L-TGF-beta1 in complex with the anchor protein LRRC33 | |
| 7Y1R | Q86YC3 | Human L-TGF-beta1 in complex with the anchor protein LRRC33 | |
| 7TTI | Q9UP95 | Human KCC1 bound with VU0463271 In an outward-open state | |
| 5MW7 | Q9Y219 | Human Jagged2 C2-EGF3 | |
| 5MW5 | Q9Y219 | Human Jagged2 C2-EGF2 | |
| 5MWF | Q9Y219 | Human Jagged2 C2-EGF2 | |
| 6BZ4 | P0DOX5 | Human IgG1 lacking complement-dependent cytotoxicity: hu3S193 Fc mutant K322A | |
| 5MOL | P01854 | Human IgE-Fc crystal structure | |
| 7ZXK | Q8NEV9 | Human IL-27 in complex with neutralizing SRF388 FAb fragment | |
| 7ZXK | Q14213 | Human IL-27 in complex with neutralizing SRF388 FAb fragment | |
| 7ZXK | 7ZXK | Human IL-27 in complex with neutralizing SRF388 FAb fragment |
